Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp224 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Caffeine upregulates hepatic SHBG production by increasing adiponectin in white adipose tissue

Brianso-Llort Laura , Fuertes-Rioja Lidia , Perez Lorena Ramos , Hernandez Cristina , Simo Rafael , Selva David

Epidemiological studies have shown that caffeine increases plasma SHBG levels and also reduce the risk of type 2 diabetes. There are no reports describing any molecular mechanism by which caffeine regulates hepatic SHBG production. The aim of the present study was to explore whether caffeine regulates SHBG production and to determine the associated molecular mechanisms. For this purpose, in vitro and in vivo studies were performed using human HepG2 cells and ...

ea0049ep753 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Resveratrol increases hepatic SHBG expression through human constitutive androstane receptor: a new Contribution to the French Paradox

Saez-Lopez Cristina , Brianso-Llort Laura , Torres-Torrenteras Javier , Simo Rafael , Hammond Geoffrey , Selva David

Sex hormone-binding globulin (SHBG) carries sex steroids in blood regulating their bioavailability. Red wine consumption increases plasma SHBG levels, and we have discovered that resveratrol, a polyphenol enriched in red wine, acts specifically through the human constitutive androstane receptor (CAR), a drug/xenobiotic detoxification gene regulator, to increase hepatic SHBG production. Chromatin immunoprecipitation and luciferase reporter gene assays show that human CAR binds ...

ea0070aep379 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

TGFβ1 downregulates hepatic SHBG production by decreasing HNF-4α levels via SMAD and STAT3 pathways

Brianso-LLort Laura , Fuertes-Rioja Lidia , Hernandez Cristina , Simo Rafael , Martinez David

Low plasmasex hormone-binding globulin (SHBG) levels are present in fatty liver disease, which represents a spectrum of diseases ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. We are interested in studying the molecular mechanisms by which plasma SHBG levels are reduced in fatty liver disease. In this regard, we have previously shown that fat accumulation in the liver reduces SHBG production by reducing hepatic nuclear fac...

ea0081p92 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Transforming growth factor beta 1: a new factor reducing hepatic sex hormone binding globulin production during liver fibrosis development

Brianso Llort Laura , Fuertes Rioja Lidia , Ramos Perez Lorena , Salcedo Allende Maria Teresa , Hernandez Cristina , Canonge Rafael Simo , Martinez David

Low plasma sex hormone-binding globulin (SHBG) levels are present in fatty liver disease, which represent a spectrum of diseases ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. We have previously determined that fat accumulation reduces SHBG production in different non-alcoholic fatty liver disease (NAFLD) mouse models and that SHBG plays an active role in the development of this disease. In the present work, we are interes...